Literature DB >> 9046334

Chromophore-modified bis-naphthalimides: synthesis and antitumor activity of bis-dibenz[de,h]isoquinoline-1,3-diones.

M F Braña1, J M Castellano, D Perron, C Maher, D Conlon, P F Bousquet, J George, X D Qian, S P Robinson.   

Abstract

The bis-dibenz[de,h]isoquinoline-1,3-diones are a new series of antitumor agents that consist of two chromophores bridged by an alkylamino linker. In the present study we have explored the effect produced by the presence of two dibenz[de,h]isoquinoline-1,3-dione moieties with different polyamine chains on cellular cytotoxicity. Bis-dibenz[de,h]isoquinoline-1,3-diones with the bridge (CH2)2-NH-(CH2)n-NH-(CH2)2, where n = 2-5, showed optimum cytotoxicity with IC50's around 10 nM. Compound 16, which has the (CH2)2-NH-(CH2)3-NH-(CH2)2 bridge, altered DNA mobility and topoisomerase I and II activity at approximately 5 microM. When tested in vivo, compound 16 increased the median survival time of mice implanted with M5076 with an optimum %T/C of 154% and produced cures in 50% of mice implanted with Lox melanoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9046334     DOI: 10.1021/jm960295k

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Synthesis and bioevaluation of 5-fluorouracil derivatives.

Authors:  Zhi-Yong Tian; Gang-Jun Du; Song-Qiang Xie; Jin Zhao; Wen-Yuan Gao; Chao-Jie Wang
Journal:  Molecules       Date:  2007-11-06       Impact factor: 4.411

2.  In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers.

Authors:  Jana Janockova; Jan Korabecny; Jana Plsikova; Katerina Babkova; Eva Konkolova; Dana Kucerova; Jana Vargova; Jan Koval; Rastislav Jendzelovsky; Peter Fedorocko; Jana Kasparkova; Viktor Brabec; Jan Rosocha; Ondrej Soukup; Slavka Hamulakova; Kamil Kuca; Maria Kozurkova
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.